Plant ID: NPO20212
Plant Latin Name: Callistemon Viminalis
Taxonomy Genus: Callistemon
Taxonomy Family: Myrtaceae
NCBI TaxonomyDB:
73737
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC90841
Ingredient ID: NPC86496
Ingredient ID: NPC78159
Ingredient ID: NPC74910
Ingredient ID: NPC71283
Ingredient ID: NPC65840
Ingredient ID: NPC62049
Ingredient ID: NPC59650
Ingredient ID: NPC51939
Ingredient ID: NPC480899
Ingredient ID: NPC480898
Ingredient ID: NPC48057
Ingredient ID: NPC46864
Ingredient ID: NPC41029
Ingredient ID: NPC40592
Ingredient ID: NPC39822
Ingredient ID: NPC37623
Ingredient ID: NPC34808
Ingredient ID: NPC320968
Ingredient ID: NPC31991
Ingredient ID: NPC31494
Ingredient ID: NPC314743
Ingredient ID: NPC307792
Ingredient ID: NPC307131
Ingredient ID: NPC301470
Ingredient ID: NPC300059
Ingredient ID: NPC299475
Ingredient ID: NPC297581
Ingredient ID: NPC29224
Ingredient ID: NPC278153
Ingredient ID: NPC271150
Ingredient ID: NPC265662
Ingredient ID: NPC261153
Ingredient ID: NPC259688
Ingredient ID: NPC257668
Ingredient ID: NPC257640
Ingredient ID: NPC257194
Ingredient ID: NPC256892
Ingredient ID: NPC249967
Ingredient ID: NPC244543
Ingredient ID: NPC242930
Ingredient ID: NPC242428
Ingredient ID: NPC241279
Ingredient ID: NPC235080
Ingredient ID: NPC233832
Ingredient ID: NPC228039
Ingredient ID: NPC226453
Ingredient ID: NPC223059
Ingredient ID: NPC222618
Ingredient ID: NPC22228
Ingredient ID: NPC219397
Ingredient ID: NPC216199
Ingredient ID: NPC208949
Ingredient ID: NPC208573
Ingredient ID: NPC206510
Ingredient ID: NPC205926
Ingredient ID: NPC200061
Ingredient ID: NPC194883
Ingredient ID: NPC189079
Ingredient ID: NPC187648
Ingredient ID: NPC18603
Ingredient ID: NPC183927
Ingredient ID: NPC182238
Ingredient ID: NPC178212
Ingredient ID: NPC17810
Ingredient ID: NPC178085
Ingredient ID: NPC174146
Ingredient ID: NPC170427
Ingredient ID: NPC15636
Ingredient ID: NPC154213
Ingredient ID: NPC153923
Ingredient ID: NPC147092
Ingredient ID: NPC146795
Ingredient ID: NPC143726
Ingredient ID: NPC133609
Ingredient ID: NPC131486
Ingredient ID: NPC129226
Ingredient ID: NPC128828
Ingredient ID: NPC127508
Ingredient ID: NPC124598
Ingredient ID: NPC122752
Ingredient ID: NPC114685
Ingredient ID: NPC110406
Ingredient ID: NPC103518
Ingredient ID: NPC103483
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Enzyme | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Drug Transporter | SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR1 | Cannabinoid CB1 receptor | P21554 | CHEMBL218 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRA2A | Alpha-2a adrenergic receptor | P08913 | CHEMBL1867 |
Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Therapeutic Target | Transient receptor potential channel | TRPV1 | Vanilloid receptor | Q8NER1 | CHEMBL4794 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 190 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT01983683 | Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00228410 | Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections | skin disease | Vancomycin (NPC314743) | NP level |
NCT01191840 | Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT00047983 | Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients | kidney disease | Arginine (NPC226453) | NP level |
NCT02432807 | Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis | bacterial conjunctivitis | Vancomycin (NPC314743) | NP level |
NCT00384527 | Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT04898348 | A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT01987895 | Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00037050 | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria | bacteriemia;gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT03796650 | Fecal Transplantation for Primary Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02092935 | A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract;macular degeneration | Beta Carotene (NPC17810) | NP level |
NCT00917826 | Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies | lymphoma | Arginine (NPC226453) | NP level |
NCT04983901 | PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | hematopoietic and lymphoid cell neoplasm | Vancomycin (NPC314743) | NP level |
NCT00124020 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT00345150 | Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls | hypertension | Arginine (NPC226453) | NP level |
NCT04678154 | Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT | infection | Vancomycin (NPC314743) | NP level |
NCT01142219 | L-Arginine and Sickle Cell Disease | sickle cell anemia | Arginine (NPC226453) | NP level |
NCT03827447 | Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02765256 | Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Vancomycin (NPC314743) | NP level |
NCT04017468 | Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion | infection | Vancomycin (NPC314743) | NP level |
NCT01515020 | Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia | nosocomial infection | Vancomycin (NPC314743) | NP level |
NCT03030248 | Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01798537 | Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections | bacteriemia;pneumonia | Vancomycin (NPC314743) | NP level |
NCT03817125 | Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention | metastatic melanoma | Vancomycin (NPC314743) | NP level |
NCT02099240 | Patients Response to Early Switch To Oral:Osteomyelitis Study | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT03446456 | Vasopressin and Pain Perception in the Brain | pain | Arginine (NPC226453) | NP level |
NCT00062647 | Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia | gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT01603446 | L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome | MELAS | Arginine (NPC226453) | NP level |
NCT02017249 | Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme | glioblastoma multiforme | Arginine (NPC226453) | NP level |
NCT04247542 | ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00217165 | Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study | bipolar disorder | Taurine (NPC300059) | NP level |
NCT00345605 | Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder | argininosuccinic aciduria | Arginine (NPC226453) | NP level |
NCT01287585 | Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy | hepatocellular carcinoma | Arginine (NPC226453) | NP level |
NCT04750902 | A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children | dental caries | Arginine (NPC226453) | NP level |
NCT03105479 | Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01222702 | Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00391001 | Taurine in Adolescents With Bipolar Disorder | bipolar disorder | Taurine (NPC300059) | NP level |
NCT01796678 | Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial | pain | Arginine (NPC226453) | NP level |
NCT00420823 | A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment | mental or behavioural disorder | Taurine (NPC300059) | NP level |
NCT01598311 | A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00056433 | Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia | sickle cell anemia | Arginine (NPC226453) | NP level |
NCT01400867 | Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections | infection | Vancomycin (NPC314743) | NP level |
NCT00091819 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT01984684 | Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | infection;bacterial disease | Vancomycin (NPC314743) | NP level |
NCT03595553 | Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | infection | Vancomycin (NPC314743) | NP level |
NCT04042077 | Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections | infection | Vancomycin (NPC314743) | NP level |
NCT02344511 | Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT03685747 | Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis | peritonitis | Vancomycin (NPC314743) | NP level |
NCT05266807 | Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence | infection | Vancomycin (NPC314743) | NP level |
NCT02291458 | L-arginine and Brown Adipose Tissue | Glucose intolerance | Arginine (NPC226453) | NP level |
NCT00423657 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT02301221 | Effect of Fecal Microbiota Transplantation in Slow Transit Constipation | Constipation | Vancomycin (NPC314743) | NP level |
NCT02663596 | Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution | kidney failure | Vancomycin (NPC314743) | NP level |
NCT03506347 | Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement | Arthropathy | Vancomycin (NPC314743) | NP level |
NCT01283581 | A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT04249336 | Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH | allergic disease | Arginine (NPC226453) | NP level |
NCT02790996 | Neonatal Vancomycin Trial | Neonatal sepsis | Vancomycin (NPC314743) | NP level |
NCT02227446 | Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO) | infection | Vancomycin (NPC314743) | NP level |
NCT00442832 | TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT05320068 | Oral Vancomycin vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection | infection | Vancomycin (NPC314743) | NP level |
NCT00223717 | Treatment of Supine Hypertension in Autonomic Failure | hypertension | Arginine (NPC226453) | NP level |
NCT02447874 | Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease | sickle cell anemia | Arginine (NPC226453) | NP level |
NCT01792804 | Staphylococcus Aureus Bacteremia Antibiotic Treatment Options | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT02743234 | Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02774382 | Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01607879 | Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation | prostate cancer | Arginine (NPC226453) | NP level |
NCT02208063 | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT00405665 | The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis | cystic fibrosis | Arginine (NPC226453) | NP level |
NCT05076955 | Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy | diabetic foot | Vancomycin (NPC314743) | NP level |
NCT04631536 | Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC | COVID-19 | Arginine (NPC226453) | NP level |
NCT00428844 | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT01439555 | Endothelial Facilitation in Alzheimer's Disease | Alzheimer disease | Arginine (NPC226453) | NP level |
NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | neoplasm | Arginine (NPC226453) | NP level |
NCT01925066 | Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation | staphylococcal pneumonia;Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT02730962 | Interventional Bioremediation of Microbiota in Metabolic Syndrome | prediabetes syndrome | Vancomycin (NPC314743) | NP level |
NCT00005107 | Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia | cirrhosis of liver | Arginine (NPC226453) | NP level |
NCT00974714 | L-arginine Effects on Chronic Hypertension in Pregnancy | preeclampsia | Arginine (NPC226453) | NP level |
NCT02504554 | Beneficial Bacteria Treatment for Autism | autism spectrum disorder | Vancomycin (NPC314743) | NP level |
NCT00157521 | L-Arginine in Pre-Eclampsia | preeclampsia | Arginine (NPC226453) | NP level |
NCT00408577 | Prevention of Cardiac and Vascular Events in Patients With NGT/IGT. | cardiovascular disease | Arginine (NPC226453) | NP level |
NCT00695903 | Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia | infective endocarditis | Vancomycin (NPC314743) | NP level |
NCT02686645 | Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT02607618 | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 | infection | Vancomycin (NPC314743) | NP level |
NCT03476317 | Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Vancomycin (NPC314743) | NP level |
NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | staphylococcal skin infections;skin disease | Vancomycin (NPC314743) | NP level |
NCT01802073 | Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT00543608 | Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia | ventilator-associated pneumonia | Vancomycin (NPC314743) | NP level |
NCT05370885 | VE202 in Patients With Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT00134433 | Endothelial Modulation for Angiogenic Therapy | coronary artery disease | Arginine (NPC226453) | NP level |
NCT02388178 | To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study | dental caries | Arginine (NPC226453) | NP level |
NCT00344916 | Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis | cirrhosis of liver | Arginine (NPC226453) | NP level |
NCT04816968 | Antibiotics Continuous Infusion at Home | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT00107952 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT05042024 | Supplementation With L-ornithine But Not L-arginine Increases Density of CD68+ and CD163+ Macrophages in Periodontitis | periodontitis | Arginine (NPC226453) | NP level |
NCT01757236 | Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection | infection | Vancomycin (NPC314743) | NP level |
NCT03679780 | The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction | cardiovascular disease | Arginine (NPC226453) | NP level |
NCT05470998 | L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity | sickle cell anemia | Arginine (NPC226453) | NP level |
NCT00314951 | Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) | commensal Clostridium infectious disease;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT00424190 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT03452189 | The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome | chronic kidney disease | Vancomycin (NPC314743) | NP level |
NCT00147368 | Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria | Plasmodium falciparum malaria | Arginine (NPC226453) | NP level |
NCT04535427 | Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis | rheumatoid arthritis | Arginine (NPC226453) | NP level |
NCT02857582 | Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01339091 | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | abscess;cellulitis;infection | Vancomycin (NPC314743) | NP level |
NCT02865616 | MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00050401 | Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support | pneumonia | Vancomycin (NPC314743) | NP level |
NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | infection | Vancomycin (NPC314743) | NP level |
NCT02600611 | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 | infection | Vancomycin (NPC314743) | NP level |
NCT01252732 | Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection | abscess;cellulitis;infection;inflammation | Vancomycin (NPC314743) | NP level |
NCT03710122 | Vancomycin for Primary Sclerosing Cholangitis | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT02179658 | A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT03580122 | The Effect of Arginine on Classic Galactosemia | classic galactosemia | Arginine (NPC226453) | NP level |
NCT01811732 | Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT01594827 | Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) | cystic fibrosis | Vancomycin (NPC314743) | NP level |
NCT01263041 | Effect of L-arginine and Glutamine on Preterm | Sepsis | Arginine (NPC226453) | NP level |
NCT00677339 | L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB) | pulmonary tuberculosis | Arginine (NPC226453) | NP level |
NCT04802837 | Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects | infection | Vancomycin (NPC314743) | NP level |
NCT04025567 | Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral | hepatocellular carcinoma | Vancomycin (NPC314743) | NP level |
NCT02466698 | Intestinal Lavage for the Treatment of Severe C. Difficile Infections | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01085760 | A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis | sclerosing cholangitis | Vancomycin (NPC314743) | NP level |
NCT03759041 | A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT01226992 | Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT01192828 | Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine | homocystinuria | Taurine (NPC300059) | NP level |
NCT00772447 | China Registration Study in Patients With Skin Infections | skin disease | Vancomycin (NPC314743) | NP level |
NCT03462459 | Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection | clostridium difficile infection;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT01388764 | Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids | Duchenne muscular dystrophy | Arginine (NPC226453) | NP level |
NCT00571766 | Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy | preeclampsia | Arginine (NPC226453) | NP level |
NCT00770341 | A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT00200746 | Treatment of Alcohol-Related Hepatitis With Arginine | Hepatitis, Alcoholic | Arginine (NPC226453) | NP level |
NCT00006136 | Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia | Beta-thalassemia | Arginine (NPC226453) | NP level |
NCT03595566 | Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | infection | Vancomycin (NPC314743) | NP level |
NCT02374853 | Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial) | infection | Vancomycin (NPC314743) | NP level |
NCT03137173 | Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections | infection | Vancomycin (NPC314743) | NP level |
NCT01499277 | Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections | infection | Vancomycin (NPC314743) | NP level |
NCT01816698 | Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive | hypertension | Taurine (NPC300059) | NP level |
NCT01266018 | Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer | small cell lung carcinoma | Arginine (NPC226453) | NP level |
NCT01975662 | Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia | Staphylococcus aureus infection | Vancomycin (NPC314743) | NP level |
NCT02426918 | Study of Debio 1450 for Bacterial Skin Infections | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT00269399 | A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) | commensal Clostridium infectious disease;Diarrhea | Vancomycin (NPC314743) | NP level |
NCT05342272 | Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction | xerostomia | Taurine (NPC300059) | NP level |
NCT02037295 | Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans | obesity | Vancomycin (NPC314743) | NP level |
NCT05256693 | Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT04075526 | Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty | osteoarthritis | Vancomycin (NPC314743) | NP level |
NCT00616304 | Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria | Plasmodium falciparum malaria | Arginine (NPC226453) | NP level |
NCT03088345 | Early Use of Vasopressin in Post-Fontan Management | congenital heart disease | Arginine (NPC226453) | NP level |
NCT04968951 | Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT03546829 | Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | non-small cell lung carcinoma | Vancomycin (NPC314743) | NP level |
NCT02440061 | Ghrelin and Beta Cell Function in Diabetes | type 2 diabetes mellitus | Arginine (NPC226453) | NP level |
NCT03964493 | TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection | gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
NCT00275418 | Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease | Crohn's disease | Beta Carotene (NPC17810) | NP level |
NCT00426933 | Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections | infection | Vancomycin (NPC314743) | NP level |
NCT02801656 | Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT03640949 | Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest | sudden cardiac arrest | Arginine (NPC226453) | NP level |
NCT00430937 | Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections | infection;skin disease | Vancomycin (NPC314743) | NP level |
NCT01597505 | Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Beta Carotene (NPC17810) | NP level |
NCT02618187 | A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis | ulcerative colitis | Vancomycin (NPC314743) | NP level |
NCT03861416 | "Unifuzol®" in Patients With Peripheral Arterial Disease | peripheral arterial disease | Arginine (NPC226453) | NP level |
NCT00137124 | L-Arginine Metabolism in Essential Hypertension | essential hypertension | Arginine (NPC226453) | NP level |
NCT02148601 | Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection | commensal Clostridium infectious disease | Vancomycin (NPC314743) | NP level |
NCT01199783 | Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment | diabetic foot | Vancomycin (NPC314743) | NP level |
NCT02516085 | Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin | Duchenne muscular dystrophy | Arginine (NPC226453) | NP level |
NCT01381354 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | multiple sclerosis | Taurine (NPC300059) | NP level |
NCT03617445 | Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT04874012 | Effect of Taurine on Glycemic, Lipid and Inflammatory Profile in Individuals With Type 2 Diabetes | type 2 diabetes mellitus | Taurine (NPC300059) | NP level |
NCT03673956 | Topical Antibiotics in Chronic Rhinosinusitis | sinusitis | Vancomycin (NPC314743) | NP level |
NCT01764750 | Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics | infection | Vancomycin (NPC314743) | NP level |
NCT04138706 | Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT04775953 | DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia | bacteriemia | Vancomycin (NPC314743) | NP level |
NCT00077675 | Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) | infection | Vancomycin (NPC314743) | NP level |
NCT01184872 | Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections | infection | Vancomycin (NPC314743) | NP level |
NCT00945152 | Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) | bacterial disease | Vancomycin (NPC314743) | NP level |
NCT00280683 | Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma | asthma | Arginine (NPC226453) | NP level |
NCT00871104 | Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis | infective endocarditis | Vancomycin (NPC314743) | NP level |
NCT00107978 | Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | staphylococcal skin infections | Vancomycin (NPC314743) | NP level |
NCT02202135 | Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. | infection | Vancomycin (NPC314743) | NP level |
NCT00344734 | Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure | congestive heart failure | Arginine (NPC226453) | NP level |
NCT01756924 | Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection | infection | Vancomycin (NPC314743) | NP level |
NCT04948814 | Application of Fecal Microbiota Transplantation in Children With ASD | autism spectrum disorder | Vancomycin (NPC314743) | NP level |
NCT01570192 | Clinical Trials to Reduce the Risk of Antimicrobial Resistance | bacterial pneumonia | Vancomycin (NPC314743) | NP level |
NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | myocardial infarction;Myocardial Ischemia | Beta Carotene (NPC17810) | NP level |
NCT00513617 | Effectiveness of Arginine as a Treatment for Sickle Cell Anemia | sickle cell anemia | Arginine (NPC226453) | NP level |
NCT01232595 | Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections | clostridium difficile infection | Vancomycin (NPC314743) | NP level |
NCT00150852 | Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus. | infection | Vancomycin (NPC314743) | NP level |
NCT04054973 | L-arginine Study for Persistent Symptoms of Schizophrenia | schizophrenia | Arginine (NPC226453) | NP level |
NCT02276482 | Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) | skin disease | Vancomycin (NPC314743) | NP level |
NCT01922011 | Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006) | osteomyelitis | Vancomycin (NPC314743) | NP level |
NCT02641236 | Gut Decontamination In Pediatric Allogeneic Hematopoietic | acute graft vs. host disease | Vancomycin (NPC314743) | NP level |
NCT00108433 | Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections | bacteriemia;gram-positive bacterial infections | Vancomycin (NPC314743) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
NCT04816968,NCT00423657,NCT01984684,NCT00945152,NCT01811732,NCT02426918,NCT01283581,NCT00424190
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
TRPV1,CNR1,CNR2,ADRA2A
NCT03446456,NCT01796678 |
BacteraemiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MA15.0 |
NCT00108433,NCT02208063,NCT01191840,NCT01798537,NCT00037050,NCT04775953
|
Skin diseaseDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA00-EM0Z |
NCT00430937,NCT00772447,NCT00210899,NCT02276482,NCT00228410
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT03759041,NCT04898348,NCT04968951,NCT05370885,NCT02618187
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT02447874,NCT00056433,NCT00513617,NCT05470998,NCT01142219
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
CNR1,TSHR,BLM,CNR2,ADRA2A
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
CNR2
NCT02765256,NCT03476317,NCT00275418 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NFKB1,CNR1
NCT02440061,NCT04874012 |
Gram-positive bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B74-1F40 |
NCT00037050,NCT00108433,NCT03964493,NCT00062647
|
Osteomyelitis or osteitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB84 |
NCT02344511,NCT01922011,NCT02099240,NCT00428844
|
Other specified pyogenic bacterial infection of skin and subcutaneous tissueDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B7Y |
NCT01925066,NCT01975662,NCT00770341,NCT01792804
|
Staphylococcal/streptococcal diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B5Y |
NCT00091819,NCT00442832,NCT00210899,NCT00107978
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
TSHR,SLCO1B1,ADRA2A,BLM
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NFKB1,TRPV1
NCT04535427 |
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NFKB1,TRPV1,CNR2
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
CNR1
NCT00047983,NCT03452189 |
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
NCT00571766,NCT00974714,NCT00157521
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT00223717,NCT00345150,NCT01816698
|
Bacterial pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.0 |
NCT00107952,NCT01570192,NCT00124020
|
DiarrhoeaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.1 |
NCT00269399,NCT00314951,NCT03462459
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT03710122,NCT01802073,NCT01085760
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ADRA2A,BLM,CNR1
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
CNR2,TSHR,BLM
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
CNR1,TSHR,CNR1
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TSHR,SLCO1B1,BLM
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CNR2,ADRA2A,CNR1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
CNR2,SLCO1B1,BLM
|
Clostridium difficile enterocolitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A04 |
NCT00384527,NCT03462459,NCT02801656,NCT02466698,NCT00269399,NCT02774382,NCT03827447,NCT05256693,NCT01226992,NCT02092935,NCT03030248,NCT03617445,NCT02743234,NCT02686645,NCT01983683,NCT02148601,NCT00314951,NCT04138706,NCT04247542,NCT03105479,NCT01222702,NCT02857582,NCT01232595,NCT02865616,NCT02179658,NCT01597505,NCT01987895,NCT03796650,NCT01598311
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT01757236,NCT03595553,NCT02374853,NCT05320068,NCT00150852,NCT01764750,NCT04802837,NCT01339091,NCT04042077,NCT02600611,NCT04017468,NCT01984684,NCT00430937,NCT02607618,NCT00003805,NCT01499277,NCT01756924,NCT01184872,NCT02202135,NCT05266807,NCT03595566,NCT01252732,NCT00077675,NCT03137173,NCT04678154,NCT02227446,NCT00426933,NCT01400867
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CNR2,CNR1
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TRPV1
NCT00280683 |
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
CNR2,ADRA2A
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
CNR2,CNR1
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
CNR1
NCT02037295 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NFKB1
NCT01381354 |
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
CNR2,TRPV1
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
TRPV1
NCT04075526 |
EndocarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB40-BA42 |
NCT00871104,NCT00695903
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT00391001,NCT00217165
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01594827,NCT00405665
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
NCT05076955,NCT01199783
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT01798537,NCT00050401
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
NCT03679780,NCT00408577
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT04948814,NCT02504554
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT01287585,NCT04025567
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000152,NCT00000161
|
Bacterial cellulitis, erysipelas or lymphangitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B70 |
NCT01252732,NCT01339091
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT00005107,NCT00344916
|
Pyogenic abscess of the skinDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B75.3 |
NCT01339091,NCT01252732
|
Dental cariesDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA08.0 |
NCT02388178,NCT04750902
|
Duchenne muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.1 |
NCT02516085,NCT01388764
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
NCT00616304,NCT00147368
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
BLM,ADRA2A
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
BLM,CNR1
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
SLCO1B1,BLM
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CNR2,BLM
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
BLM,CNR1
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
SLCO1B1,BLM
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
SLCO1B1,BLM
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CNR2,CNR1
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NFKB1,CNR2
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CNR2,BLM
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
CNR2,CNR1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
TSHR,BLM
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
BLM,ADRA2A
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NFKB1
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
NFKB1
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
ADRA2A
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
TRPV1
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
TRPV1
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1
|
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
CNR1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
CNR1
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
CNR1
|
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
ADRA2A
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
CNR1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
|
Knee osteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA01 |
TRPV1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NFKB1
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
NFKB1
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
CNR1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NFKB1
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1
|
Anorexia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B80 |
CNR1
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
CNR1
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NFKB1
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
Visual system diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9E1Z |
TRPV1
|
Lower limb mononeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C11 |
TRPV1
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
TRPV1
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ADRA2A
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
CNR1
|
Other specified disorders of carbohydrate absorption or transportDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C61.Y |
NCT02291458
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03546829
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT01263041
|
Mental/behavioural/neurodevelopmental disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6E20-6E8Z |
NCT00420823
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00134433
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04631536
|
Other specified conjunctivitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A60.Y |
NCT02432807
|
Argininosuccinic aciduriaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50.A0 |
NCT00345605
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
NCT03673956
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NCT04249336
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT01607879
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000541
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
NCT04983901
|
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT03861416
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT02641236
|
Disorders of methionine cycle or sulphur amino acid metabolismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50.B |
NCT01192828
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
NCT00000161
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT01324115
|
NosocomialDisease Category: X.Extension CodesDisease ICD-11 Code: XB25 |
NCT01515020
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT03640949
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
NCT03506347
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT05042024
|
Beta thalassaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A50.2 |
NCT00006136
|
Intermediate hyperglycaemia, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.Z |
NCT02730962
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
NCT00000541
|
XerostomiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.1 |
NCT05342272
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
NCT00917826
|
Sepsis of fetus or newbornDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA60 |
NCT02790996
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
NCT00137124
|
Pneumonia due to StaphylococcusDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.06 |
NCT01925066
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT03817125
|
Alcoholic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94.1 |
NCT00200746
|
Ventilation associated with injury or harm in therapeutic useDisease Category: 23.External causes of morbidity or mortalityDisease ICD-11 Code: PK81.0 |
NCT00543608
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT00344734
|
Galactose-1-phosphate uridyltransferase deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C51.40 |
NCT03580122
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT04054973
|
MelasmaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60.1 |
NCT01603446
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
NCT02663596
|
PeritonitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC50 |
NCT03685747
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
NCT01439555
|
Tuberculosis of the respiratory systemDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10 |
NCT00677339
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT02017249
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT01266018
|
ConstipationDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.0 |
NCT02301221
|
Structural developmental anomaly of heart or great vessels, unspecifiedDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA8Z |
NCT03088345
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT01252732
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
TSHR
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
SLCO1B1
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
ADRA2A
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
NFKB1
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
SLCO1B1
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
ADRA2A
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SLCO1B1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
CNR1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
BLM
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CNR1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
BLM
|